Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up
Table 2
Periprocedural characteristics.
General anaesthesia, n (%)
166 (100)
TEE guiding, n (%)
166 (100)
ASD diameter on TEE (mm)+
15.6 ± 6.1
ASD balloon sizing (mm)+
20.9 ± 6.7
Device
Occlutech Flex I, n (%)
116 (69.9)
Occlutech Flex II, n (%)
50 (30.1)
Device diameter (mm)
24 (10–40)
In-hospital complication
Device embolization
3 (1.8%)
Pericardial effusion
1 (0.6%)
New-onset AF
3 (1.8%)
Groin hematoma
13 (7.8%)
TTE shunt, n (%)
Color-Doppler
23 (14.1%)
Data are presented as median (range). +Data are presented as mean± standard deviation. TEE, transesophageal echocardiogram; ASD, atrial septal defect; AF, atrial fibrillation; TTE, transthoracic echocardiogram.
